Application of FOLFIRINOX regimen in conversion therapy of unresectable pancreatic cancer / 国际外科学杂志
International Journal of Surgery
;
(12): 346-350, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-863328
ABSTRACT
Pancreatic cancer is a common malignant tumor of the digestive system with high degree of malignancy and difficulty in diagnosis.Patients with unresectable pancreatic cancer can regain the opportunity to receive surgical treatment with a combination of treatments known as conversion therapy. FOLFIRINOX regimen (Oxaliplatin+ Irinotecan+ 5-Fluorouracil+ Calcium folate) is an effective convesion therapy for unresectable pancreatic cancer, increasing surgical resection rate and prolongation of survival.This review aims to review the application of the FOLFIRINOX regimen in conversion therapy of unresectable pancreatic cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
International Journal of Surgery
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS